Overview

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Treatments:
Pregabalin